Aptevo Therapeutics Inc (APVO)
0.7677
-0.01
(-1.70%)
USD |
NASDAQ |
Jun 14, 16:00
0.6699
-0.10
(-12.74%)
After-Hours: 20:00
Aptevo Therapeutics Cash from Operations (Quarterly): -6.651M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -6.651M |
| December 31, 2023 | -5.253M |
| September 30, 2023 | -6.24M |
| June 30, 2023 | -4.803M |
| March 31, 2023 | 4.566M |
| December 31, 2022 | -5.939M |
| September 30, 2022 | -6.896M |
| June 30, 2022 | -3.07M |
| March 31, 2022 | -5.117M |
| December 31, 2021 | -3.88M |
| September 30, 2021 | -5.242M |
| June 30, 2021 | -5.053M |
| March 31, 2021 | -7.504M |
| December 31, 2020 | -6.123M |
| September 30, 2020 | -7.387M |
| June 30, 2020 | -4.633M |
| March 31, 2020 | -11.18M |
| December 31, 2019 | -5.10M |
| September 30, 2019 | -7.548M |
| Date | Value |
|---|---|
| June 30, 2019 | -15.89M |
| March 31, 2019 | -13.84M |
| December 31, 2018 | -7.292M |
| September 30, 2018 | -11.15M |
| June 30, 2018 | -16.01M |
| March 31, 2018 | -16.98M |
| December 31, 2017 | -15.42M |
| September 30, 2017 | -1.616M |
| June 30, 2017 | -12.51M |
| March 31, 2017 | -12.03M |
| December 31, 2016 | -6.665M |
| September 30, 2016 | -0.134M |
| June 30, 2016 | -15.95M |
| March 31, 2016 | -14.11M |
| December 31, 2015 | -7.684M |
| September 30, 2015 | -9.355M |
| June 30, 2015 | -15.80M |
| March 31, 2015 | -15.92M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-15.89M
Minimum
Jun 2019
4.566M
Maximum
Mar 2023
-5.947M
Average
-5.596M
Median
Cash from Operations (Quarterly) Benchmarks
| Johnson & Johnson | 3.657B |
| BioSig Technologies Inc | -1.314M |
| Adial Pharmaceuticals Inc | -1.626M |
| IN8bio Inc | -7.919M |
| NovaBay Pharmaceuticals Inc | -1.572M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | -0.003M |
| Free Cash Flow | -22.95M |
| Free Cash Flow Per Share (Quarterly) | -9.685 |
| Free Cash Flow Yield | -7.65K% |